Johnson and Johnson announced a proposed settlement of up to 5.5 billion dollars to resolve thousands of lawsuits claiming the company’s talc-based products caused cancer. The settlement comes after years of legal battles in American courts, where juries repeatedly found the company liable for failing to warn consumers about health risks associated with talc use.
The company faces claims from people who say they developed ovarian cancer and mesothelioma after using J&J’s baby powder and other talc products for years or decades. Many of these cases involved women and families who used the powder regularly as part of their daily hygiene routines. In some trials, juries awarded individual plaintiffs hundreds of millions of dollars in damages, creating mounting financial pressure on the company to settle the broader litigation.
J&J has consistently maintained that its talc products are safe and do not cause cancer. However, the company discontinued sales of talc-based baby powder in the United States in 2020, citing declining consumer demand rather than safety concerns. The product remained available in other countries. This decision came amid growing consumer concerns and negative media coverage about talc and cancer links.
The settlement, if approved by courts, would resolve the majority of pending cases and bring closure to what has become one of the largest mass litigation battles in American legal history. The exact amount each person receives will depend on factors including the severity of their illness and when they were diagnosed. Legal experts note that settlements of this scale typically require approval from federal judges overseeing the cases.
This legal battle reveals how major corporations face significant financial consequences when evidence of product harm emerges. J&J has faced billions in settlements for various legal issues in recent years beyond this talc litigation. Consumer safety advocates have used the case as an example of why companies must conduct thorough testing before launching products intended for regular use by children and families.
The settlement represents an attempt by J&J to move past years of costly trials and negative publicity. However, the company continues to face similar litigation in other countries where talc products remain sold. The case has also prompted increased scrutiny of how consumer product companies test and communicate risks associated with their products.
Source: BBC World News
